McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
A rapidly rising patient pool is anticipated to be the key driver of the global healthcare supply chain management market during the forecast period. Fortune Business Insights provides valuable market...
Boosting its leadership pool as it moves into full growth mode, Carmel-based medical device company PathogenX has named tech entrepreneur Jamie Moriarty to its board of directors. The company also announced...
As growth stocks continue their rise, it's getting harder and harder to find growth stocks trading at attractive valuations. But if you use our POWR Ratings systems, you can find top growth stocks trading...
Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.
The Zacks Analyst Blog Highlights: Becton, Dickinson and Co, Hill-Rom Holdings, Owens & Minor, McKesson Corp and Meridian Bioscience
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast of the earnings conference...
Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.
Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.
Investors are optimistic about Quest Diagnostics (DGX) owing to strong demand for COVID-19 testing and well-positioned growth strategy.
Henry Schein's (HSIC) recent majority ownership in Stradis Healthcare will advance the former's commitment to offer specialty solutions to customers.
McKesson (MCK) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically,
According to FTC, the Illumina (ILMN) and Grail merger will diminish the scope of innovation in the U.S. market for MCED tests.
Dow Takes a Break as We Prepare to End Month, Quarter
Allscripts' (MDRX) Sunrise platform gets selected by Mercy Iowa City, thereby enabling the former to help in delivering better patient outcomes and accelerating the future of healthcare.
A Very Strong Q1 and 2021 Earnings Picture
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...
, /PRNewswire/ -- Republic Services, Inc. (NYSE: RSG) today announced that healthcare industry executive , Ph.D., has been appointed to its Board of Directors, bringing its membership to a total of 12....
, /PRNewswire/ -- The report has been added to offering.